Objectives We compared biological repair after acute myocardial infarction (AMI) with selected porcine progenitor cell populations. Background Cell types and mechanisms responsible for myocardial repair after AMI remain uncertain. Methods In a blinded, randomized study, we infused autologous late-outgrowth endothelial progenitor cells (EPC) (n! 10, 34 " 22 # 106 CD29-31-positive, capable of tube formation), allogeneic green fluorescent peptide–labeled mesenchymal stem cells (MSC) (n! 11, 10 " 2 # 106 CD29-44-90-positive, capable of adipogenic and osteo-genic differentiation), or vehicle (CON) (n! 12) in the circumflex artery 1 week after AMI. Systolic function (ejec-tion fraction), left ventricular (LV) end-diastolic and end-systo...
Clinical and basic studies of cell-based myocardial therapy have proceeded at a rapid pace. Cell the...
AIMS: Controversy exists in regard to the beneficial effects of transplanting cardiac or somatic pro...
Aim: Deciding the best cell type for cardiac regeneration remains a big challenge. No studies have d...
ObjectivesWe compared biological repair after acute myocardial infarction (AMI) with selected porcin...
OBJECTIVES: We compared biological repair after acute myocardial infarction (AMI) with selected porc...
Introduction: We previously showed that human cardiomyocyte progenitor cells (hCMPCs) injected after...
Objective—To test the potential of mesoangioblasts (Mabs) in reducing postischemic injury in compari...
ObjectiveRecent evidence suggests that the effects of mesenchymal progenitor cell transplantation in...
Objective - To test the potential of mesoangioblasts (Mabs) in reducing postischemic injury in compa...
Following ischemic injury, the myocardium undergoes extensive cardiomyocyte loss, scar formation and...
Objective - To test the potential of mesoangioblasts (Mabs) in reducing postischemic injury in compa...
Objective—To test the potential of mesoangioblasts (Mabs) in reducing postischemic injury in compari...
<p><strong>BACKGROUND</strong>: Myocardial infarction (MI) is an irreversible cardiomyocytes injury ...
Progressive contractile dysfunction of viable myocardium that surrounds a large infarct leads to hea...
Human induced pluripotent stem cells (hiPSCs) hold promise for myocardial repair following injury, b...
Clinical and basic studies of cell-based myocardial therapy have proceeded at a rapid pace. Cell the...
AIMS: Controversy exists in regard to the beneficial effects of transplanting cardiac or somatic pro...
Aim: Deciding the best cell type for cardiac regeneration remains a big challenge. No studies have d...
ObjectivesWe compared biological repair after acute myocardial infarction (AMI) with selected porcin...
OBJECTIVES: We compared biological repair after acute myocardial infarction (AMI) with selected porc...
Introduction: We previously showed that human cardiomyocyte progenitor cells (hCMPCs) injected after...
Objective—To test the potential of mesoangioblasts (Mabs) in reducing postischemic injury in compari...
ObjectiveRecent evidence suggests that the effects of mesenchymal progenitor cell transplantation in...
Objective - To test the potential of mesoangioblasts (Mabs) in reducing postischemic injury in compa...
Following ischemic injury, the myocardium undergoes extensive cardiomyocyte loss, scar formation and...
Objective - To test the potential of mesoangioblasts (Mabs) in reducing postischemic injury in compa...
Objective—To test the potential of mesoangioblasts (Mabs) in reducing postischemic injury in compari...
<p><strong>BACKGROUND</strong>: Myocardial infarction (MI) is an irreversible cardiomyocytes injury ...
Progressive contractile dysfunction of viable myocardium that surrounds a large infarct leads to hea...
Human induced pluripotent stem cells (hiPSCs) hold promise for myocardial repair following injury, b...
Clinical and basic studies of cell-based myocardial therapy have proceeded at a rapid pace. Cell the...
AIMS: Controversy exists in regard to the beneficial effects of transplanting cardiac or somatic pro...
Aim: Deciding the best cell type for cardiac regeneration remains a big challenge. No studies have d...